# Mitral Valve Repair System to Percutaneously Treat Moderate to Severe Regurgitation Using Alfieri Edge-to-Edge Technique

> **NIH NIH R44** · MEDFREE, INC. · 2021 · $1,331,698

## Abstract

The MEDFREE® Valve Repair System will innovatively improve upon the current market leading MitraClip
device, while leveraging and building on the proven percutaneous Alfieri edge-to-edge repair technique. We
aim to address this vastly unmet percutaneous structural heart market by delivering a simpler, easier-to-use
device in a smaller 12 Fr catheter system that can be used by a single operator.

## Key facts

- **NIH application ID:** 10258797
- **Project number:** 2R44HL147825-02A1
- **Recipient organization:** MEDFREE, INC.
- **Principal Investigator:** Raghuveer Basude
- **Activity code:** R44 (R01, R21, SBIR, etc.)
- **Funding institute:** NIH
- **Fiscal year:** 2021
- **Award amount:** $1,331,698
- **Award type:** 2
- **Project period:** 2020-01-02 → 2023-03-31

## Primary source

NIH RePORTER: https://reporter.nih.gov/project-details/10258797

## Citation

> US National Institutes of Health, RePORTER application 10258797, Mitral Valve Repair System to Percutaneously Treat Moderate to Severe Regurgitation Using Alfieri Edge-to-Edge Technique (2R44HL147825-02A1). Retrieved via AI Analytics 2026-05-22 from https://api.ai-analytics.org/grant/nih/10258797. Licensed CC0.

---

*[NIH grants dataset](/datasets/nih-grants) · CC0 1.0*
